Natural Desiccated Thyroid vs Levothyroxine: Which Is Better?
Compare natural desiccated thyroid (NDT) and levothyroxine side by side. Learn the pros, cons, research, and how to choose the right thyroid medication for you.
Derek Olson, DO · Osteopathic Physician · · 13 min read
Reviewed by Brian Rodgers, DO
Key Takeaways
- ✓Levothyroxine (T4-only) is the standard of care, but up to 15% of patients continue to feel unwell despite 'normal' lab values.
- ✓Natural desiccated thyroid (NDT) provides both T4 and T3, plus T2, T1, and calcitonin — more closely mimicking your natural thyroid output.
- ✓A landmark 2013 study found that 49% of patients preferred NDT over levothyroxine and experienced more weight loss on NDT.
- ✓NDT isn't perfect — T3 content can cause fluctuations, and batch consistency has been questioned (though modern manufacturing is tightly regulated).
- ✓The best choice depends on your individual biochemistry, symptoms, and how well you convert T4 to T3.
The Great Thyroid Medication Debate
If you're on thyroid medication — or about to start — one of the biggest decisions you'll face is which type of medication is right for you. For decades, the conventional approach has been simple: levothyroxine (synthetic T4) for everyone. But a growing number of patients and practitioners are questioning whether this one-size-fits-all approach truly serves everyone well.
Enter natural desiccated thyroid (NDT) — the original thyroid medication that was used for over 100 years before synthetic options arrived. NDT has experienced a dramatic resurgence in recent years as patients and integrative practitioners seek alternatives for those who don't feel well on levothyroxine alone.
In this guide, we'll give you an honest, evidence-based comparison of both options so you can have an informed conversation with your healthcare provider about what's right for you.
Understanding the Two Options
Levothyroxine (Synthetic T4)
Levothyroxine is a synthetic form of thyroxine (T4) — the most abundant thyroid hormone your gland produces. Brand names include Synthroid, Levoxyl, Tirosint, and Euthyrox. It's been the standard treatment for hypothyroidism since the 1960s and is one of the most prescribed medications in the world.
The premise behind levothyroxine is straightforward: give the body T4, and it will convert what it needs into the active T3 hormone using deiodinase enzymes in the liver, kidneys, and other tissues.
What levothyroxine contains:
- T4 (thyroxine) only
- Inactive ingredients vary by brand (fillers, dyes, lactose in some formulations)
Natural Desiccated Thyroid (NDT)
NDT is made from the dried thyroid glands of pigs (porcine). It's been used since the 1890s — long before synthetic options existed — and remains available as a prescription medication. Brands include Armour Thyroid, NP Thyroid, WP Thyroid, and Nature-Throid (though availability of some brands has fluctuated).
What NDT contains:
- T4 (thyroxine)
- T3 (triiodothyronine) — the active hormone
- T2 (diiodothyronine) — emerging research suggests metabolic benefits
- T1 (monoiodothyronine) — role still being studied
- Calcitonin — involved in calcium metabolism
- Other thyroid-derived proteins and cofactors
The standard ratio in NDT is approximately 4.2:1 (T4:T3), which is close to — but not identical to — the human thyroid's natural output ratio of roughly 11:1 to 14:1. This means NDT provides proportionally more T3 than your thyroid would naturally produce.
Head-to-Head Comparison
| Feature | Levothyroxine (T4) | NDT (T4 + T3) |
|---|---|---|
| Hormones provided | T4 only | T4, T3, T2, T1, calcitonin |
| Requires T4→T3 conversion | Yes — fully dependent | Partially — provides direct T3 |
| Dosing precision | Very precise (mcg increments) | Grain-based (less granular) |
| Consistency between batches | Very consistent | Good (FDA-regulated), rare variation |
| T3 peaks after dosing | None (steady T4 release) | Yes — T3 peaks 2–4 hours post-dose |
| FDA approved | Yes | Yes (grandfathered, regulated) |
| Available generically | Yes | Some brands only |
| Cost | Low (generic) to moderate (brand) | Moderate |
| Patient preference (studies) | ~30% prefer in head-to-head | ~49% prefer in head-to-head |
| Best for poor T4→T3 converters | No — may be insufficient | Yes — bypasses conversion issue |
What the Research Says
The Hoang 2013 Study: A Turning Point
The most cited head-to-head comparison is the randomized, double-blind, crossover trial by Hoang et al. published in the Journal of Clinical Endocrinology & Metabolism in 2013. This study enrolled 70 patients with hypothyroidism and compared NDT (Armour Thyroid) to levothyroxine over two 16-week periods.
Key findings:
- 49% of patients preferred NDT vs. 19% who preferred levothyroxine (the rest had no preference)
- Patients on NDT lost an average of 3 pounds more than on levothyroxine
- There were no significant differences in cognitive function, quality of life, or symptoms between the groups overall
- TSH was slightly more suppressed on NDT due to T3 content
This study was groundbreaking because it was the first well-designed trial to directly compare the two — and it showed that NDT was at least as effective as levothyroxine, with nearly half of patients actively preferring it.
The Conversion Problem: Why T4-Only Fails Some People
The fundamental assumption behind T4-only therapy is that your body can adequately convert T4 into T3. For many people, this works fine. But for a significant minority — estimated at 10–15% of hypothyroid patients — this conversion process is impaired.
Factors that impair T4-to-T3 conversion include:
| Factor | How It Impairs Conversion |
|---|---|
| DIO2 gene polymorphism | Reduces deiodinase enzyme efficiency by up to 25% |
| Selenium deficiency | Deiodinase enzymes are selenium-dependent |
| Iron deficiency | Impairs overall thyroid hormone metabolism |
| Chronic stress/high cortisol | Shunts T4 toward reverse T3 instead of active T3 |
| Gut inflammation | Reduces peripheral T3 conversion (20% occurs in the gut) |
| Caloric restriction/dieting | Body downregulates T3 production to conserve energy |
| Chronic illness | "Sick euthyroid" — T3 drops as a protective mechanism |
For these individuals, taking levothyroxine alone may normalize TSH on paper while leaving them with inadequate T3 levels — resulting in persistent symptoms like fatigue, brain fog, weight gain, depression, and cold intolerance despite "normal" labs.
The DIO2 Gene: A Game-Changer
In 2009, Panicker et al. published a landmark study showing that people with a common polymorphism in the DIO2 gene (which encodes the deiodinase type 2 enzyme) had worse psychological wellbeing on T4-only therapy compared to combination T4/T3 therapy. This gene variant is present in approximately 16% of the population.
If you carry this variant, your body is inherently less efficient at converting T4 to T3 — which means T4-only therapy may never fully resolve your symptoms, no matter how perfectly your TSH is optimized.
The Case for Levothyroxine
To be fair, levothyroxine has genuine advantages that make it the right choice for many people:
- Stable blood levels: T4 has a long half-life (approximately 7 days), providing consistent hormone levels throughout the day without peaks and troughs.
- Precise dosing: Available in very specific mcg increments (25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200), allowing fine-tuned adjustments.
- Vast clinical experience: Decades of research and clinical use with well-understood pharmacokinetics.
- Simplicity: Once-daily dosing with straightforward monitoring via TSH.
- Works well for most people: The majority of hypothyroid patients (85%+) do well on T4-only therapy when properly dosed.
If you're on levothyroxine and feeling great — your energy is good, your weight is stable, your mood is clear, and your labs look optimal — there's no reason to switch. The medication is working as intended.
The Case for NDT
NDT shines in specific situations where levothyroxine falls short:
- Persistent symptoms despite "normal" labs: If your TSH is optimized on levothyroxine but you still feel hypothyroid, the addition of T3 (whether via NDT or combination therapy) may resolve lingering symptoms.
- Poor T4-to-T3 conversion: If your free T4 is adequate but free T3 is low, you may benefit from direct T3 supplementation.
- DIO2 gene polymorphism: Genetic testing can identify those who are less efficient T4-to-T3 converters.
- Patient preference: Some people simply feel better on NDT. The Hoang study validated this subjective experience with objective data.
- Philosophical alignment: Some patients prefer a whole-gland product over an isolated synthetic molecule, viewing it as more aligned with how the body naturally functions.
Common Concerns About NDT — Addressed
"NDT isn't consistent between batches." This concern originated decades ago but is largely outdated. Modern NDT products are FDA-regulated, manufactured under strict Good Manufacturing Practice (GMP) guidelines, and tested for potency. Armour Thyroid, for example, is standardized to contain precise amounts of T4 and T3 per grain.
"T3 in NDT causes dangerous peaks." NDT does produce a T3 peak approximately 2–4 hours after dosing, but this is generally well-tolerated and can be managed by splitting the dose (taking half in the morning and half in the early afternoon). The peak mimics the natural circadian T3 pulse your thyroid would produce.
"NDT suppresses TSH too much." Because NDT contains direct T3, it often lowers TSH more than an equivalent dose of levothyroxine. This doesn't necessarily indicate over-replacement — it reflects the direct pituitary effect of T3. Monitoring should include free T3 and free T4, not just TSH.
Want help figuring out which approach might work best for you? Get your free wellness blueprint to review your labs and symptoms — we'll help you weigh the options.
Combination Therapy: The Middle Ground
If NDT feels like too big a leap, there's a middle path: synthetic combination therapy using levothyroxine plus liothyronine (synthetic T3, brand name Cytomel). This approach gives you:
- The stability and precise dosing of synthetic T4
- The benefits of direct T3 supplementation
- The ability to adjust T4 and T3 doses independently
Typical starting protocols add 5–10 mcg of liothyronine to an existing levothyroxine regimen (reducing T4 dose slightly to compensate). Some practitioners use sustained-release compounded T3 for smoother blood levels.
How to Decide: A Practical Framework
| If This Describes You... | Consider This Option |
|---|---|
| Feeling well on current levothyroxine | Stay on levothyroxine — no change needed |
| Persistent symptoms despite optimized TSH | Trial of NDT or add liothyronine |
| Low free T3 with adequate free T4 | NDT or combination T4+T3 |
| DIO2 gene variant confirmed | Combination therapy or NDT strongly favored |
| Want whole-gland, multi-hormone approach | NDT |
| Need very precise T3 dose control | Synthetic T4 + synthetic T3 (liothyronine) |
| Newly diagnosed, first-time treatment | Either — levothyroxine is reasonable first-line; NDT also valid |
Monitoring on NDT vs. Levothyroxine
Regardless of which medication you choose, proper monitoring is essential. Here's what to test and when:
| Test | On Levothyroxine | On NDT / Combination |
|---|---|---|
| TSH | Primary marker; aim 1.0–2.5 | May run lower (0.5–2.0); less reliable as sole marker |
| Free T4 | Should be mid-range to upper third | Often runs lower (T3 compensates); mid-range acceptable |
| Free T3 | Important but often unchecked | Critical — aim upper third of range |
| Reverse T3 | Check if symptoms persist | Check if symptoms persist |
| TPO/TgAb | Monitor autoimmune activity | Monitor autoimmune activity |
Timing matters: On NDT, draw labs in the morning before your dose (trough levels) for the most accurate picture. If you take a split dose, skip the afternoon dose the day before labs and take your morning dose after the blood draw.
Making the Switch: What to Expect
If you're transitioning from levothyroxine to NDT, here's what a typical process looks like:
- Work with a knowledgeable provider. Not all practitioners are comfortable prescribing NDT. Integrative, functional, and naturopathic doctors are typically most experienced.
- Convert your dose. A rough conversion: 1 grain (60–65 mg) of NDT ≈ 88–100 mcg of levothyroxine. Your practitioner may start slightly lower and titrate up.
- Expect an adjustment period. It can take 4–8 weeks to stabilize on a new medication. During this time, you may notice changes in energy, mood, and body temperature as your body adapts to receiving direct T3.
- Recheck labs at 6–8 weeks. Full thyroid panel including TSH, free T4, free T3, and reverse T3.
- Fine-tune. Dose adjustments in quarter-grain (15 mg) increments based on labs and symptoms.
The Bottom Line
There is no single "best" thyroid medication — there's only the best medication for you. Levothyroxine works well for the majority of hypothyroid patients and remains a solid, evidence-based choice. But if you're among the significant minority who continue to struggle despite optimized T4 therapy, NDT or combination T4/T3 therapy deserves serious consideration.
The most important factors are: how you feel, what your comprehensive labs show (not just TSH), and whether you're working with a practitioner who's willing to look beyond the standard algorithm to find what actually works for your body.
Both levothyroxine and NDT are safe, effective, and evidence-supported. The debate isn't about which is universally better — it's about which is better for you.
Not sure which thyroid medication approach is right for you? Get your free wellness blueprint — we'll help you interpret your labs, explore your options, and find the path that helps you feel your best.
Already have your blueprint? Find a practitioner who specializes in your needs.